GLP Watchdog

Does TRICARE (Military) Pay for GLP-1 Medications? (2026)

TRICARE (Military) covers GLP-1 medications only in limited cases; prior authorization is required, and members who are approved typically pay $0-$38 a month.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

Where TRICARE (Military) stands[3]
Limited
9,600,000 members · Prior authorization needed
Limited

Where Each Medication Stands[3]

MedicationWhat TRICARE does
Wegovy (semaglutide)Covered by TRICARE Prime and TRICARE Select with prior authorization through Express Scripts (TPHARM contractor for DoD). Effective August 31, 2025, weight-loss medications including Wegovy and Zepbound are no longer covered for non-Prime / non-Select beneficiaries. Initial PA approval is for 12 months; annual renewal requires the original TRICARE PA. Wegovy may be covered for patients age 12+ meeting criteria.
Ozempic (semaglutide)Covered for type 2 diabetes diagnosis under the TRICARE pharmacy benefit.
Zepbound (tirzepatide)Covered for TRICARE Prime/Select beneficiaries age 18+ with prior authorization. Zepbound is NOT approved for patients under 18 under TRICARE PA criteria. Not covered for non-Prime/non-Select beneficiaries as of Aug 31, 2025.
Mounjaro (tirzepatide)Covered for type 2 diabetes; step therapy may apply.
Copay when it is covered$0-$38 / month

What a GLP-1 costs a TRICARE (Military) member

At TRICARE (Military)'s typical copay of $0-$38 a month, a covered year of a GLP-1 costs $0 to $456. That is $3,732 to $4,188 less than a year of Wegovy bought for cash from NovoCare ($4,188), and Zepbound's LillyDirect price of $299 to $449 a month is further above it still.

No compounded seller beats a covered TRICARE fill: the cheapest, Collective at $59/mo, still costs $252 a year more than the top of the TRICARE range, so an approval is worth pursuing.

TRICARE (Military) is a government plan, and every manufacturer savings card for Wegovy, Ozempic, Zepbound and Mounjaro excludes government-plan members. Novo Nordisk's Wegovy terms say the exclusion holds even if you pay cash and never bill the plan, so the cash comparison for a TRICARE member is the manufacturer's self-pay price or a compounded seller.

After a Denial from TRICARE (Military)

A TRICARE denial leaves two routes: an appeal, and paying cash. With a prescription, a brand-name GLP-1 is generally an eligible HSA or FSA medical expense[1]. Compounded semaglutide and tirzepatide from licensed 503A pharmacies[2] cost far less than the brand; the cheapest sellers are listed below.

Where to go if TRICARE (Military) says no

The 8 cheapest cash-pay compounded GLP-1s

Cheapest cash-pay compounded GLP-1 sellers
#SellerMonthly priceVisit
1Collective
Compounded semaglutide
$59/moVisit
2Boston Medical Group
Compounded semaglutide
$66/moVisit
3OurView Health
Compounded semaglutide
$75/moVisit
4Ivim Health
Compounded semaglutide
$75/moVisit
5Embody
Compounded semaglutide
$79/moVisit
6Lean Meds
Compounded semaglutide
$79/moVisit
7NextMeds
Compounded semaglutide
$79/moVisit
8NuuVim
Compounded semaglutide
$79/moVisit

Top-rated sellers that bill insurance

30 sellers say they accept insurance. Confirm with the seller that it bills TRICARE before you book.

Sellers that bill insurance
#SellerCash priceVisit
1Shapely$99/moVisit
2Rivo Health$149/moVisit
3NovoCare Pharmacy$149/moVisit
4Cost Plus Drugs$279/moVisit
5Knownwell$349/moVisit

Every seller and price, side by side: compare all sellers.

Our picks

#ProviderScore
1Trimi HealthVisit
2EmbodyVisit
3CoreAge RxVisit
4bmiMDVisit
5Live VitalVisit

Frequently Asked Questions

Covered by TRICARE Prime and TRICARE Select with prior authorization through Express Scripts (TPHARM contractor for DoD). Effective August 31, 2025, weight-loss medications including Wegovy and Zepbound are no longer covered for non-Prime / non-Select beneficiaries. Initial PA approval is for 12 months; annual renewal requires the original TRICARE PA. Wegovy may be covered for patients age 12+ meeting criteria.
Covered for type 2 diabetes diagnosis under the TRICARE pharmacy benefit.
Covered for TRICARE Prime/Select beneficiaries age 18+ with prior authorization. Zepbound is NOT approved for patients under 18 under TRICARE PA criteria. Not covered for non-Prime/non-Select beneficiaries as of Aug 31, 2025.
Covered for type 2 diabetes; step therapy may apply.
Members who are approved typically pay $0-$38 a month, which is $0 to $456 over a year. As a TRICARE member you cannot use a manufacturer savings card.
Appeal first: ask TRICARE for the written denial and the criteria it applied, and have your prescriber answer them in a letter of medical necessity. If the appeal fails, the cheapest cash route is compounded semaglutide or tirzepatide, from Collective at $59/mo or Boston Medical Group at $66/mo. 30 sellers say they bill insurance. A compounded drug is not FDA-approved as a finished product.

Glossary

The words sellers use, defined. Tap any term.

How coverage looks nationallyWork out the cash-pay difference
Sources & methodology — as of September 2026
  1. 1.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.GLP Watchdog insurer coverage index (manually curated formulary data)— GLP Watchdog.